Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$73,560,808
+$9,981,901 QoQ
Shares Held
3,032,185
-26.1% QoQ
Ownership
2.92%
of shares outstanding
% of Portfolio
2.53%
of 13F equity value
Holder Rank
#13
of 210 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GENERAL ATLANTIC, L.P. holds $541,727,121 across 5 Biotechnology names. NRIX ranks #3 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHVS |
Pharvaris N.V.
|
6,550,757 | $226,525,177 | |
| 2 | SPTX |
Seaport Therapeutics, Inc.
|
6,101,582 | $132,526,361 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
This page
|
3,032,185 | $73,560,808 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
357,791 | $67,007,098 | |
| 5 | PBLS |
Parabilis Medicines, Inc.
|
1,538,461 | $42,107,677 |
All Filings in NRIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,560,808 | 3,032,185 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $63,578,907 | 4,101,865 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $92,899,106 | 4,897,159 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||